• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道微生物多样性与致盲性糖尿病视网膜病变的相关性。

Correlation of gut microbial diversity to sight-threatening diabetic retinopathy.

机构信息

Shri Bhagwan Mahavir Vitreoretinal Services, Sankara Nethralaya, Sankara Nethralaya, 18 College Road, Chennai, 600 006, Tamil Nadu, India.

School of Optometry and Vision Science, University of New South Wales, Sydney, Australia.

出版信息

BMC Microbiol. 2024 Sep 13;24(1):342. doi: 10.1186/s12866-024-03496-x.

DOI:10.1186/s12866-024-03496-x
PMID:39271995
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11395485/
Abstract

PURPOSE

To determine the association of gut microbiome diversity and sight-threatening diabetic retinopathy (STDR) amongst patients with pre-existing diabetes.

METHODS

A cross-sectional study was performed, wherein 54 participants selected in total were placed into cases cohort if diagnosed with STDR and those without STDR but had a diagnosis of diabetes mellitus of at least 10-year duration were taken as controls. Statistical analysis comparing the gut microbial alpha diversity between cases and control groups as well as patients differentiated based on previously hypothesized Bacteroidetes/Firmicutes(B/F) ratio with an optimal cut-off 1.05 to identify patients with STDR were performed.

RESULTS

Comparing gut microbial alpha diversity did not show any difference between cases and control groups. However, statistically significant difference was noted amongst patients with B/F ratio ≥1.05 when compared to B/F ratio < 1.05; ACE index [Cut-off < 1.05:773.83 ± 362.73; Cut-off > 1.05:728.03 ± 227.37; p-0.016]; Chao1index [Cut-off < 1.05:773.63 ± 361.88; Cut-off > 1.05:728.13 ± 227.58; p-0.016]; Simpson index [Cut-off < 1.05:0.998 ± 0.001; Cut-off > 1.05:0.997 ± 0.001; p-0.006]; Shannon index [Cut-off < 1.05:6.37 ± 0.49; Cut-off > 1.05:6.10 ± 0.43; p-0.003]. Sub-group analysis showed that cases with B/F ratio ≥ 1.05, divided into proliferative diabetic retinopathy (PDR) and clinically significant macular edema (CSME), showed decreased diversity compared to controls (B/F ratio < 1.05). For PDR, all four diversity indices significantly decreased (p < 0.05). However, for CSME, only Shannon and Simpson indices showed significant decrease in diversity (p < 0.05).

CONCLUSIONS

Based on clinical diagnosis, decreasing gut microbial diversity was observed among patients with STDR, although not statistically significant. When utilizing B/F ratio, the decreasing gut microbial diversity in STDR patients seems to be associated due to species richness and evenness in PDR when compared to decreasing species richness in CSME.

摘要

目的

在患有糖尿病前期的患者中,确定肠道微生物多样性与威胁视力的糖尿病视网膜病变(STDR)之间的关联。

方法

进行了一项横断面研究,总共选择了 54 名参与者,如果被诊断为 STDR,则将其纳入病例队列,如果没有 STDR,但患有至少 10 年糖尿病病史,则将其作为对照组。对病例组和对照组之间的肠道微生物 alpha 多样性进行了统计学分析,以及基于先前假设的拟杆菌/厚壁菌(B/F)比率进行了分析,最佳截断值为 1.05,以识别患有 STDR 的患者。

结果

比较肠道微生物 alpha 多样性,病例组和对照组之间没有差异。然而,当比较 B/F 比率≥1.05的患者与 B/F 比率<1.05的患者时,观察到统计学显著差异; ACE 指数[截止值<1.05:773.83±362.73;截止值>1.05:728.03±227.37;p-0.016];Chao1 指数[截止值<1.05:773.63±361.88;截止值>1.05:728.13±227.58;p-0.016];辛普森指数[截止值<1.05:0.998±0.001;截止值>1.05:0.997±0.001;p-0.006];香农指数[截止值<1.05:6.37±0.49;截止值>1.05:6.10±0.43;p-0.003]。亚组分析显示,B/F 比率≥1.05的病例组,分为增殖性糖尿病视网膜病变(PDR)和临床显著黄斑水肿(CSME),与对照组(B/F 比率<1.05)相比,多样性降低。对于 PDR,所有四个多样性指数均显著降低(p<0.05)。然而,对于 CSME,只有香农和辛普森指数显示多样性显著降低(p<0.05)。

结论

根据临床诊断,在患有 STDR 的患者中观察到肠道微生物多样性降低,尽管没有统计学意义。当使用 B/F 比率时,与 CSME 中物种丰富度降低相比,STDR 患者的肠道微生物多样性降低似乎与物种丰富度和均匀度有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd84/11395485/9e39e6957df2/12866_2024_3496_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd84/11395485/48e765d8dbc2/12866_2024_3496_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd84/11395485/9e39e6957df2/12866_2024_3496_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd84/11395485/48e765d8dbc2/12866_2024_3496_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd84/11395485/9e39e6957df2/12866_2024_3496_Fig2_HTML.jpg

相似文献

1
Correlation of gut microbial diversity to sight-threatening diabetic retinopathy.肠道微生物多样性与致盲性糖尿病视网膜病变的相关性。
BMC Microbiol. 2024 Sep 13;24(1):342. doi: 10.1186/s12866-024-03496-x.
2
Association Between Gut Microbial Abundance and Sight-Threatening Diabetic Retinopathy.肠道微生物丰度与威胁视力的糖尿病视网膜病变之间的关联
Invest Ophthalmol Vis Sci. 2021 Jun 1;62(7):19. doi: 10.1167/iovs.62.7.19.
3
Role of cystatin C in the detection of sight-threatening diabetic retinopathy in Asian Indians with type 2 diabetes.胱抑素 C 在检测亚洲 2 型糖尿病患者并发威胁视力的糖尿病视网膜病变中的作用。
J Diabetes Complications. 2023 Aug;37(8):108545. doi: 10.1016/j.jdiacomp.2023.108545. Epub 2023 Jun 15.
4
Profile of sight-threatening diabetic retinopathy and its awareness among patients with diabetes mellitus attending a tertiary care center in Kashmir, India.印度克什米尔一家三级医疗中心糖尿病患者中威胁视力的糖尿病视网膜病变概况及其知晓情况。
Indian J Ophthalmol. 2021 Nov;69(11):3123-3130. doi: 10.4103/ijo.IJO_831_21.
5
Gut microbiome in diabetic retinopathy: A systematic review and meta-analysis.肠道微生物组与糖尿病视网膜病变:系统评价和荟萃分析。
Microb Pathog. 2024 Apr;189:106590. doi: 10.1016/j.micpath.2024.106590. Epub 2024 Feb 23.
6
Screening and identification of gut anaerobes (Bacteroidetes) from human diabetic stool samples with and without retinopathy in comparison to control subjects.比较伴有和不伴有视网膜病变的糖尿病患者粪便样本与对照受试者的肠道厌氧菌(拟杆菌门)的筛选和鉴定。
Microb Pathog. 2019 Apr;129:88-92. doi: 10.1016/j.micpath.2019.01.025. Epub 2019 Jan 29.
7
Association between serum fibroblast growth factor 21 level and sight-threatening diabetic retinopathy in Chinese patients with type 2 diabetes.血清成纤维细胞生长因子 21 水平与中国 2 型糖尿病患者视力威胁性糖尿病视网膜病变的关系。
BMJ Open Diabetes Res Care. 2021 Mar;9(1). doi: 10.1136/bmjdrc-2021-002126.
8
Correlation between markers of renal function and sight-threatening diabetic retinopathy in type 2 diabetes: a longitudinal study in an Indian clinic population.2型糖尿病患者肾功能指标与威胁视力的糖尿病视网膜病变之间的相关性:一项针对印度门诊患者的纵向研究
BMJ Open Diabetes Res Care. 2020 May;8(1). doi: 10.1136/bmjdrc-2020-001325.
9
The Core Gut Microbiome of the American Cockroach, Periplaneta americana, Is Stable and Resilient to Dietary Shifts.美国蟑螂(美洲大蠊)的核心肠道微生物群稳定且对饮食变化具有抗性。
Appl Environ Microbiol. 2016 Oct 27;82(22):6603-6610. doi: 10.1128/AEM.01837-16. Print 2016 Nov 15.
10
Influence of glycosylated hemoglobin on sight-threatening diabetic retinopathy: a population-based study.糖化血红蛋白对威胁视力的糖尿病视网膜病变的影响:一项基于人群的研究。
Diabetes Res Clin Pract. 2011 May;92(2):168-73. doi: 10.1016/j.diabres.2011.01.006. Epub 2011 Feb 5.

本文引用的文献

1
Association Between Gut Microbial Abundance and Sight-Threatening Diabetic Retinopathy.肠道微生物丰度与威胁视力的糖尿病视网膜病变之间的关联
Invest Ophthalmol Vis Sci. 2021 Jun 1;62(7):19. doi: 10.1167/iovs.62.7.19.
2
Alterations in the gut bacterial microbiome in people with type 2 diabetes mellitus and diabetic retinopathy.2 型糖尿病合并糖尿病视网膜病变患者肠道细菌微生物组的改变。
Sci Rep. 2021 Feb 2;11(1):2738. doi: 10.1038/s41598-021-82538-0.
3
Diabetic retinopathy screening guidelines in India: All India Ophthalmological Society diabetic retinopathy task force and Vitreoretinal Society of India Consensus Statement.
印度糖尿病视网膜病变筛查指南:全印度眼科协会糖尿病视网膜病变工作组和印度玻璃体视网膜学会共识声明。
Indian J Ophthalmol. 2021 Mar;69(3):678-688. doi: 10.4103/ijo.IJO_667_20.
4
The Gut-Eye Axis: Lessons Learned from Murine Models.肠-眼轴:从小鼠模型中获得的经验教训。
Ophthalmol Ther. 2020 Sep;9(3):499-513. doi: 10.1007/s40123-020-00278-2. Epub 2020 Jul 2.
5
Screening and identification of gut anaerobes (Bacteroidetes) from human diabetic stool samples with and without retinopathy in comparison to control subjects.比较伴有和不伴有视网膜病变的糖尿病患者粪便样本与对照受试者的肠道厌氧菌(拟杆菌门)的筛选和鉴定。
Microb Pathog. 2019 Apr;129:88-92. doi: 10.1016/j.micpath.2019.01.025. Epub 2019 Jan 29.
6
Update of inflammatory proliferative retinopathy: Ischemia, hypoxia and angiogenesis.炎症性增殖性视网膜病变的更新:缺血、缺氧与血管生成。
Curr Res Transl Med. 2019 May;67(2):62-71. doi: 10.1016/j.retram.2019.01.005. Epub 2019 Jan 23.
7
Diabetic gut microbiota dysbiosis as an inflammaging and immunosenescence condition that fosters progression of retinopathy and nephropathy.糖尿病肠道微生物失调作为一种促炎和免疫衰老状态,促进了视网膜病变和肾病的进展。
Biochim Biophys Acta Mol Basis Dis. 2019 Jul 1;1865(7):1876-1897. doi: 10.1016/j.bbadis.2018.09.032. Epub 2018 Oct 1.
8
Dysbiosis in the Gut Bacterial Microbiome of Patients with Uveitis, an Inflammatory Disease of the Eye.葡萄膜炎(一种眼部炎症性疾病)患者肠道细菌微生物群的生态失调
Indian J Microbiol. 2018 Dec;58(4):457-469. doi: 10.1007/s12088-018-0746-9. Epub 2018 Jun 4.
9
The salivary microbiome of diabetic and non-diabetic adults with periodontal disease.牙周病的糖尿病和非糖尿病成人的唾液微生物组。
J Periodontol. 2019 Jan;90(1):26-34. doi: 10.1002/JPER.18-0167. Epub 2018 Sep 5.
10
The Role of Microbiota in Retinal Disease.微生物群在视网膜疾病中的作用。
Adv Exp Med Biol. 2018;1074:429-435. doi: 10.1007/978-3-319-75402-4_53.